Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384072849> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4384072849 endingPage "2005" @default.
- W4384072849 startingPage "1999" @default.
- W4384072849 abstract "Background and Aim: The occurrence of urinary tract infection (UTI) in type 2 diabetes (T2DM) administered with sodium glucose co-transporter-2 (SGLT2) inhibitors are still debatable. The present study aimed to assess the occurrence of UTI in T2DM patients taking SGLT-2 inhibitors to regulate their blood sugar levels. Patients and Methods: This cross-sectional study was carried out on 369 T2DM patients investigated in the Nephrology division of Khyber Teaching Hospital, Peshawar from January 2022 to December 2022. Dapagliflozin and empagliflozin were SGLT-2 inhibitors drugs given to each individual. Patient’s detailed history and genitourinary infections were noted from medical records. Pain during micturition, micturition urgency, redness, abdominal pain, vomiting, and frequency of micturition, fever, soreness, and diarrhea were recorded using questionnaire based proforma. Results: Of the total 369 patients, the frequency of patients administered with dapagliflozin and empagliflozin was 178 (48.2%) and 191 (51.8%) respectively. Among 178 patients, there were 112 (62.9%) male and 66 (37.1%) females. Among 191 patients, there were 136 (71.2%) male and 55 (28.8%) females. The occurrence of UTIs in patients using dapagliflozin and empagliflozin was 18 (10.1%) and 28 (14.7%) respectively." @default.
- W4384072849 created "2023-07-13" @default.
- W4384072849 creator A5013510279 @default.
- W4384072849 creator A5020919180 @default.
- W4384072849 creator A5026458348 @default.
- W4384072849 creator A5027430971 @default.
- W4384072849 creator A5028039627 @default.
- W4384072849 creator A5047056607 @default.
- W4384072849 creator A5062954626 @default.
- W4384072849 date "2023-06-28" @default.
- W4384072849 modified "2023-10-03" @default.
- W4384072849 title "Occurence of urinary tract infections in type 2 diabetes mellitus patients taking Sodium-Glucose Co-Transporter-2 (SGLT-2) inhibitors to regulate their blood sugar levels" @default.
- W4384072849 doi "https://doi.org/10.53730/ijhs.v7ns1.14444" @default.
- W4384072849 hasPublicationYear "2023" @default.
- W4384072849 type Work @default.
- W4384072849 citedByCount "0" @default.
- W4384072849 crossrefType "journal-article" @default.
- W4384072849 hasAuthorship W4384072849A5013510279 @default.
- W4384072849 hasAuthorship W4384072849A5020919180 @default.
- W4384072849 hasAuthorship W4384072849A5026458348 @default.
- W4384072849 hasAuthorship W4384072849A5027430971 @default.
- W4384072849 hasAuthorship W4384072849A5028039627 @default.
- W4384072849 hasAuthorship W4384072849A5047056607 @default.
- W4384072849 hasAuthorship W4384072849A5062954626 @default.
- W4384072849 hasBestOaLocation W43840728491 @default.
- W4384072849 hasConcept C126322002 @default.
- W4384072849 hasConcept C134018914 @default.
- W4384072849 hasConcept C175768497 @default.
- W4384072849 hasConcept C2775887513 @default.
- W4384072849 hasConcept C2777180221 @default.
- W4384072849 hasConcept C2777422806 @default.
- W4384072849 hasConcept C2777451236 @default.
- W4384072849 hasConcept C2780485761 @default.
- W4384072849 hasConcept C2780852908 @default.
- W4384072849 hasConcept C2910068830 @default.
- W4384072849 hasConcept C555293320 @default.
- W4384072849 hasConcept C71924100 @default.
- W4384072849 hasConcept C77411442 @default.
- W4384072849 hasConcept C90924648 @default.
- W4384072849 hasConceptScore W4384072849C126322002 @default.
- W4384072849 hasConceptScore W4384072849C134018914 @default.
- W4384072849 hasConceptScore W4384072849C175768497 @default.
- W4384072849 hasConceptScore W4384072849C2775887513 @default.
- W4384072849 hasConceptScore W4384072849C2777180221 @default.
- W4384072849 hasConceptScore W4384072849C2777422806 @default.
- W4384072849 hasConceptScore W4384072849C2777451236 @default.
- W4384072849 hasConceptScore W4384072849C2780485761 @default.
- W4384072849 hasConceptScore W4384072849C2780852908 @default.
- W4384072849 hasConceptScore W4384072849C2910068830 @default.
- W4384072849 hasConceptScore W4384072849C555293320 @default.
- W4384072849 hasConceptScore W4384072849C71924100 @default.
- W4384072849 hasConceptScore W4384072849C77411442 @default.
- W4384072849 hasConceptScore W4384072849C90924648 @default.
- W4384072849 hasIssue "S1" @default.
- W4384072849 hasLocation W43840728491 @default.
- W4384072849 hasOpenAccess W4384072849 @default.
- W4384072849 hasPrimaryLocation W43840728491 @default.
- W4384072849 hasRelatedWork W1976944453 @default.
- W4384072849 hasRelatedWork W2199901734 @default.
- W4384072849 hasRelatedWork W2336452419 @default.
- W4384072849 hasRelatedWork W2807204184 @default.
- W4384072849 hasRelatedWork W2975677680 @default.
- W4384072849 hasRelatedWork W3033667127 @default.
- W4384072849 hasRelatedWork W4237238868 @default.
- W4384072849 hasRelatedWork W42427464 @default.
- W4384072849 hasRelatedWork W4282975599 @default.
- W4384072849 hasRelatedWork W4383555461 @default.
- W4384072849 hasVolume "7" @default.
- W4384072849 isParatext "false" @default.
- W4384072849 isRetracted "false" @default.
- W4384072849 workType "article" @default.